• Search chemicals, activators, Inhibitors, APIs, intermediates and raw materials.

602-55-1 (9-Phenylanthracene)

1

Identification

9-Phenylanthracene 9-Phenylanthracene
Name 9-Phenylanthracene
Formula C20H14
MW 254.33
CAS No. 602-55-1
EINECS 210-019-8
Smiles C1(C2=CC=CC=C2)=C(C=CC=C3)C3=CC4=CC=CC=C14
Synonyms 9-phenylanthracene
InChI InChI=1S/C20H14/c1-2-8-15(9-3-1)20-18-12-6-4-10-16(18)14-17-11-5-7-13-19(17)20/h1-14H
2

Introduction

Background Information

3

Protocol(Only for Reference)

Cell Experiment

Animal Experiment

4

Physical and Chemical Properties

Appearance: EBNumber:EB000034575

Storage condition

Solubility

5

Mechanism and Indication

Signaling Pathways
Target
Research Area
Indications
6

Clinical Information

Product Name Sponsor & Collaborators Indications Start Date End Date Phase
7

Safety Data of 9-Phenylanthracene

´╗┐Hazard Symbols : N
´╗┐Risk Statements : 50/53
Safety Statements : 60-61
WGKGermany : 3
8

Spectral Information

9

Suppliers List

10

Related Products

Other Forms of 602-55-1

Name CAS No Formula MW

Recommended Compounds in

Name CAS No Formula MW

Recommended Compounds in Same Indication

Name CAS No Formula MW
11

Route of Synthesis

12

References

Protocol Reference

13

More Information

9-Phenylanthracene

Tags: buy 602-55-1 IC50 | 602-55-1 price | 602-55-1 cost | 602-55-1 solubility | 602-55-1 purchase | 602-55-1 manufacturer | 602-55-1 research buy | 602-55-1 order | 602-55-1 MSDS | 602-55-1 chemical structure | 602-55-1 Storage condition | 602-55-1 molecular weight | 602-55-1 mw | 602-55-1 datasheet | 602-55-1 supplier | 602-55-1 cell line | 602-55-1 NMR | 602-55-1 MS | 602-55-1 IR | 602-55-1 solubility | 602-55-1 Safe information | 602-55-1 Qc and Spectral Information | 602-55-1 Clinical Information | 602-55-1 Clinical Trial | 602-55-1 Route of Synthesis | 602-55-1 storage condition | 602-55-1 diseases and conditions | 602-55-1 flash point | 602-55-1 boiling point | 602-55-1 melting point | 602-55-1 storage condition | 602-55-1 brand